Twist Bioscience Joins Lilly TuneLab for Antibody Discovery
SOUTH SAN FRANCISCO, Calif. — September 16, 2026 Twist Bioscience Corporation announced an agreement with Lilly TuneLab, the collaborative...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SOUTH SAN FRANCISCO, Calif. — September 16, 2026 Twist Bioscience Corporation announced an agreement with Lilly TuneLab, the collaborative...
NEW YORK — September 9, 2026 Schrödinger, Inc. announced the formation of Tectora Therapeutics, a new biotechnology company focused...
HONG KONG and STANFORD, Calif., June 12, 2026 Simcere Pharmaceutical Group Limited has entered into a strategic research collaboration...
BASEL, Switzerland, June 12, 2026 Novartis announced new Phase III data at the European Academy of Allergy and Clinical...
BOSTON and SHENZHEN, China, June 10, 2026 XtalPi, a global leader in AI and robotics-driven drug discovery, has announced...
TOKYO, Japan & CAMBRIDGE, Mass., March 13, 2026 PRISM BioLab Co., Ltd. and Receptor.AI Inc. have announced a strategic...
